Cost of poor blood pressure control in the UK: 62 000 unnecessary deaths per year

Journal of Human Hypertension

Volumn 17, Issue 7, 2003, Pages 455-457

  He, F J ^a   MacGregor, G A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Blood pressure control; Ischaemic heart disease; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALCULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COST CONTROL; DEATH; FAMILY; HEALTH CARE COST; HEALTH SERVICE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; META ANALYSIS; PHYSICAL DISABILITY; PROSPECTIVE STUDY; RISK FACTOR; STROKE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

ADULT; AGED; CEREBROVASCULAR ACCIDENT; GREAT BRITAIN; HUMANS; HYPERTENSION; META-ANALYSIS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 0042370506     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001581     Document Type: Article

References (11)

1. Ezzati M et al; the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-1360.
2. Murray CJL et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003; 361: 717-725.
3. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
4. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: Results from the Health Survey for England 1998. Hypertension 2001; 38: 827-832.
5. Coronary heart disease statistics. British Heart Foundation Statistics Database 2002. http://www.dphpc.ox.ac.uk/bhfhprg/stats/2000/index.html
6. McMahon S et al. Blood pressure, stroke, and coronary heart disease, Part 1, Prolonged differences in BP: Prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
7. SHEP Coopeative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
8. Staessen JA et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-764.
9. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
10. Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762.
11. Brown MJ et al. Better blood pressure control: How to combine drugs. J Hum Hypertens 2003; 17: 81-86.